Fysan Pharmaceuticals Private Limited
About Fysan Pharmaceuticals Private Limited
Data last updated:
Fysan Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85300PN2016PTC166869. Its GSTIN is 27AACCF9459K2Z0 (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Akshay Ashok Rokade and Zeeshan Ali Tijarat Ali Khan.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2020, the company reported a revenue of ₹3.22 Lakh, a decline of 62% compared to the previous year. For the same year it recorded a net loss of ₹1.5 Lakh (net margin -46.6%) and EBITDA of -₹1.39 Lakh (EBITDA margin -43.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fysan Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 2 Al – Karim Complex Upper Ground Floor Cts No. 789/1 Bhawa, Ni Peth, Pune, Maharashtra, India – 411002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Fysan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fysan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fysan Pharmaceuticals Private Limited, buy the company report.
Financials of Fysan Pharmaceuticals Private Limited
FY 2020 filings availableFysan Pharmaceuticals Private Limited reported revenue of ₹3.22 Lakh (down 62% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹3.22 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.39 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.5 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -43.1% | |||
| Net Profit Margin | -46.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Fysan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fysan Pharmaceuticals Private Limited
Fysan Pharmaceuticals has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshay Ashok Rokade | Director | 20 Oct 2016 | 10 Years 0 Months | Current |
| Zeeshan Ali Tijarat Ali Khan | Director | 20 Oct 2016 | 10 Years 0 Months | Current |
| Mohd Gufran Mohd Shaukat Shaikh | Director | 20 Oct 2016 | 10 Years 0 Months | Current |
| Adil Mahamudmiya Patil | Director | 20 Oct 2016 | 10 Years 0 Months | Current |
| Shoyabkhan Salimkhan Pathan | Director | 20 Oct 2016 | 10 Years 0 Months | Current |
Peer comparison
Fysan Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medineeds Pharmaceuticals Private Limited | ₹3.25 Lakh (FY 2019) | Ranchi, Jharkhand, India | ||||
| Aamidex Healthcare Private Limited | ₹3.25 Lakh (FY 2025) | -72.0% | Mayur Vihar Ph, Delhi, India | |||
| Pushpa Pharmaceuticals Private Limited | ₹3.24 Lakh (FY 2023) | -66.0% | Lucknow, Uttar Pradesh, India | |||
| Fysan Pharmaceuticals Private Limitedthis company | ₹3.22 Lakh (FY 2020) | -₹1.5 Lakh | -46.6% | -62.0% | Pune, Maharashtra, India | |
| Prickom Pharmaceuticals Private Limited | ₹3.22 Lakh (FY 2025) | 34.0% | Lucknow, Uttar Pradesh, India | |||
| Snego Pharmaceuticals Private Limited | ₹3.21 Lakh (FY 2023) | -23.0% | Via-Danpur, Odisha, India |
To see the full peer comparison of Fysan Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Fysan Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Fysan Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fysan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fysan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fysan Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCF9459K2Z0 | Maharashtra | Active | 24 May 2018 |
To see the full GST registrations and return filing status of Fysan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fysan Pharmaceuticals Private Limited has 6 board changes on record since 2016: 5 appointments and 1 cessation. The latest: Muktadir Jahir Sayyed ceased to be Director on 27 Mar 2017.
Frequently asked questions
Fysan Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 October 2016 (10+ years old) and is registered under CIN U85300PN2016PTC166869.
Fysan Pharmaceuticals has 5 current directors:
- Akshay Ashok Rokade - Director
- Zeeshan Ali Tijarat Ali Khan - Director
- Mohd Gufran Mohd Shaukat Shaikh - Director
- Adil Mahamudmiya Patil - Director
- Shoyabkhan Salimkhan Pathan - Director
The latest financial statements of Fysan Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Fysan Pharmaceuticals is 27AACCF9459K2Z0, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Fysan Pharmaceuticals is U85300PN2016PTC166869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fysan Pharmaceuticals was incorporated on 20 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Fysan Pharmaceuticals by revenue are Medineeds Pharmaceuticals Private Limited, Aamidex Healthcare Private Limited, Pushpa Pharmaceuticals Private Limited, Prickom Pharmaceuticals Private Limited, Snego Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Muktadir Jahir Sayyed ceased to be Director on 27 Mar 2017. Adil Mahamudmiya Patil was appointed as Director on 20 Oct 2016. Akshay Ashok Rokade was appointed as Director on 20 Oct 2016. Fysan Pharmaceuticals has 6 board changes on record in total.
The registered office of Fysan Pharmaceuticals is at Shop No 2 Al – Karim Complex Upper Ground Floor Cts No. 7891 Bhawa, Ni Peth, Pune, Maharashtra, India – 411002.
Fysan Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Fysan Pharmaceuticals is compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.